Newbridge Financial Services Group, Inc. Tg Therapeutics, Inc. Transaction History
Newbridge Financial Services Group, Inc.
- $275 Million
- Q3 2024
A detailed history of Newbridge Financial Services Group, Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 1,700 shares of TGTX stock, worth $53,142. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,700
Previous 3,084
44.88%
Holding current value
$53,142
Previous $54,000
27.78%
% of portfolio
0.01%
Previous 0.02%
Shares
15 transactions
Others Institutions Holding TGTX
# of Institutions
341Shares Held
87.6MCall Options Held
2.35MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA15.4MShares$481 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$356 Million0.0% of portfolio
-
State Street Corp Boston, MA9.09MShares$284 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.58MShares$112 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA3.21MShares$100 Million0.01% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.54B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...